# Vaccination for STI Prevention

> Patient Education: STI Prevention

## Overview

Vaccines are powerful tools for preventing certain sexually transmitted infections. Currently, effective vaccines exist for Human Papillomavirus (HPV) and Hepatitis B. Additionally, Hepatitis A vaccination is recommended for certain populations at higher risk through sexual transmission.

---

## Complexity Level 1: Basic Understanding

### Why Get Vaccinated?

- Vaccines prevent infection before it happens
- They protect you and your partners
- Some vaccines prevent cancers caused by infections
- Vaccination is safe and well-tested

### Available Vaccines

**HPV Vaccine**
- Prevents genital warts
- Prevents cervical cancer and other cancers
- Recommended for preteens through age 26
- Can be given up to age 45 in some cases

**Hepatitis B Vaccine**
- Prevents liver infection
- Prevents liver cancer and liver failure
- Recommended for all infants and unvaccinated adults

**Hepatitis A Vaccine**
- Prevents liver infection spread through oral-anal contact
- Recommended for men who have sex with men and others at risk

---

## Complexity Level 2: Fundamental Concepts

### HPV Vaccine (Gardasil 9)

#### What It Prevents

HPV causes:
- Genital warts
- Cervical cancer
- Anal cancer
- Throat cancer
- Penile cancer
- Vaginal and vulvar cancers

#### Who Should Get It

| Age Group | Recommendation |
|-----------|---------------|
| 11-12 years | Routine vaccination (2 doses) |
| 13-26 years | Catch-up vaccination (2-3 doses) |
| 27-45 years | Based on individual decision with provider |

#### Dosing Schedule

**Ages 9-14 (before 15th birthday):**
- 2 doses, 6-12 months apart

**Ages 15-26 (or immunocompromised):**
- 3 doses: 0, 2, and 6 months

### Hepatitis B Vaccine

#### What It Prevents

Hepatitis B can cause:
- Acute liver infection
- Chronic liver disease
- Liver cirrhosis
- Liver cancer
- Death (in severe cases)

#### Transmission Routes

- Sexual contact (vaginal, anal, oral)
- Sharing needles
- Mother to child at birth
- Contact with infected blood

#### Who Should Get It

- All infants (standard childhood vaccination)
- Unvaccinated adults with risk factors:
  - Multiple sexual partners
  - Sex partners of Hepatitis B-positive people
  - Men who have sex with men
  - People who inject drugs
  - Healthcare workers
- All unvaccinated adults 19-59 years
- Adults 60+ with risk factors

#### Dosing Schedule

**Standard 3-dose series:**
- Dose 1: Day 0
- Dose 2: 1-2 months after first
- Dose 3: 6 months after first

**2-dose option (Heplisav-B):**
- Dose 1: Day 0
- Dose 2: 1 month later

### Hepatitis A Vaccine

#### Why It Matters for Sexual Health

- Transmitted through fecal-oral route
- Oral-anal contact is a risk factor
- Outbreaks have occurred in MSM communities

#### Who Should Get It

- Men who have sex with men
- People who use recreational drugs
- People with chronic liver disease
- People experiencing homelessness
- Travelers to endemic areas

#### Dosing Schedule

- 2 doses, 6-12 months apart (or combo vaccine with Hep B)

---

## Complexity Level 3: Detailed Knowledge

### HPV Vaccine: In-Depth

#### Types Covered by Gardasil 9

| HPV Types | Associated Conditions |
|-----------|----------------------|
| 6, 11 | 90% of genital warts |
| 16, 18 | 70% of cervical cancers |
| 31, 33, 45, 52, 58 | Additional 20% of cervical cancers |

#### Efficacy Data

**In clinical trials:**
- Nearly 100% effective against HPV types covered
- Protection documented for 10+ years (ongoing studies)
- Prevents precancerous lesions that lead to cancer

**Real-world impact:**
- HPV infections in teen girls dropped 88% since vaccine introduced
- Cervical precancers decreased 40% in young women
- Genital warts cases dramatically reduced

#### Common Questions

**"I already have HPV. Should I still get vaccinated?"**
Yes. Even if you have one HPV type, the vaccine protects against other types you haven't been exposed to.

**"I'm older than 26. Is it too late?"**
The vaccine can be given up to age 45. Benefits decrease with age and sexual experience (more prior HPV exposure), but there's still value. Discuss with your provider.

**"Do I still need Pap smears if vaccinated?"**
Yes. The vaccine doesn't cover all cancer-causing HPV types, and you may have been exposed before vaccination.

### Hepatitis B: In-Depth

#### Why Adults Need Vaccination

- Many adults missed childhood vaccination
- Sexual transmission is common
- Hepatitis B is 50-100 times more infectious than HIV
- Chronic infection can develop without symptoms

#### Checking Immunity

**Blood tests can show:**
- HBsAg: Current infection
- Anti-HBs: Immunity (from vaccine or past infection)
- Anti-HBc: Past or current infection

**After vaccination series:**
- Anti-HBs â‰¥10 mIU/mL indicates protection
- Some people need additional doses if not protected

#### Special Considerations

**Healthcare workers:**
- Should confirm immunity with blood test
- May need revaccination if not protected

**HIV-positive individuals:**
- May have reduced vaccine response
- Double doses or additional doses sometimes needed
- Confirm immunity after series

**Sexual partners of HBV-positive people:**
- Should be vaccinated immediately
- Hepatitis B Immune Globulin (HBIG) may be given for recent exposure

### Combined Vaccine Options

**Twinrix (Hepatitis A + Hepatitis B):**
- 3 doses: 0, 1, and 6 months
- Convenient for those needing both
- Accelerated schedule available for travelers

### Side Effects

#### HPV Vaccine Side Effects

**Common (not dangerous):**
- Injection site pain (90%)
- Redness and swelling at site
- Headache
- Fatigue
- Muscle pain
- Nausea

**Rare:**
- Fainting (especially in adolescents - stay seated 15 minutes after)
- Allergic reactions (very rare)

#### Hepatitis B Vaccine Side Effects

**Common:**
- Sore arm (up to 25%)
- Fever (rare, less than 1%)

**Serious side effects:** Extremely rare

---

## Complexity Level 4: Advanced Understanding

### HPV Vaccine: Advanced Topics

#### Cervical Cancer Elimination

**WHO Strategy Goals:**
- 90% of girls vaccinated by age 15
- 70% of women screened by ages 35 and 45
- 90% of women with precancer/cancer treated
- Could eliminate cervical cancer as public health problem

**Countries approaching elimination:**
- Australia projected to eliminate by 2035
- Strong school-based vaccination programs key to success

#### Gender-Neutral Vaccination

**Rationale:**
- Men get HPV-related cancers too (anal, throat, penile)
- Reduces transmission to partners
- Achieves herd immunity faster
- Protects MSM who don't benefit from female-only programs

**Impact of male vaccination:**
- Reduces overall HPV circulation
- Protects unvaccinated individuals
- Cost-effective when considering all prevented cancers

#### Therapeutic HPV Vaccines

**Currently in development:**
- Designed to treat existing HPV infections
- Target HPV-16/18 related precancers
- Not yet available but promising

### Hepatitis B: Advanced Topics

#### Immunization Strategy Changes

**New CDC recommendation (2022):**
- All adults 19-59 should be vaccinated
- Not just those with "risk factors"
- Acknowledges incomplete vaccination coverage
- Removes need for risk assessment discussion

#### Chronic Hepatitis B Considerations

**People with chronic HBV should:**
- Not receive Hepatitis B vaccine (won't help)
- Get Hepatitis A vaccine (prevent additional liver damage)
- Have partners and family tested and vaccinated
- Receive ongoing monitoring and treatment

#### Post-Exposure Prophylaxis

**After sexual exposure to HBV-positive person:**

| Vaccination Status | Recommendation |
|-------------------|----------------|
| Unvaccinated | HBIG + start vaccine series |
| Incomplete series | Complete series + may add HBIG |
| Completed series | Test immunity; HBIG if not immune |

**Timing:** Within 24 hours, up to 14 days (less effective with delay)

### Vaccine Hesitancy and Counseling

#### Common Concerns About HPV Vaccine

**"It encourages sexual activity"**
- Research shows no difference in sexual behavior between vaccinated and unvaccinated teens
- Given at age 11-12 to ensure protection before exposure, not to encourage activity

**"It's too new"**
- Used since 2006 with excellent safety record
- Over 270 million doses given worldwide
- Extensive ongoing safety monitoring

**"Natural immunity is better"**
- HPV infection doesn't always create lasting immunity
- Can get infected multiple times
- Vaccine creates stronger, more consistent immune response

#### Effective Communication Strategies

**Same-way, same-day approach:**
- Recommend HPV vaccine the same way as other adolescent vaccines
- Give on the same day as other recommended vaccines
- Strong provider recommendation is most effective factor

**Addressing parental concerns:**
- Listen without judgment
- Provide accurate information
- Focus on cancer prevention
- Offer time but schedule follow-up

---

## Complexity Level 5: Expert/Comprehensive

### Public Health Impact and Policy

#### Cost-Effectiveness Analysis

**HPV vaccination:**
- Cost per quality-adjusted life year (QALY): Well below thresholds for cost-effectiveness
- Most cost-effective when given at target ages (11-12)
- Catch-up vaccination still cost-effective through age 26
- Adult vaccination (27-45) less cost-effective but valuable for some individuals

**Hepatitis B vaccination:**
- Universal infant vaccination: Highly cost-effective
- Adult catch-up: Cost-effective, especially for high-risk groups
- Prevents expensive chronic disease management and liver transplants

#### Global Vaccination Disparities

**HPV vaccine access:**
- High-income countries: Good coverage
- Low-income countries: Improving but gaps remain
- GAVI has helped introduce HPV vaccine in 40+ countries
- Single-dose schedules under consideration for easier implementation

**Hepatitis B:**
- Included in childhood vaccination programs globally
- Birth dose critical to prevent mother-to-child transmission
- Global coverage ~80% but varies significantly by region

### Immunological Considerations

#### HPV Vaccine Mechanism

**Virus-like particles (VLPs):**
- Contain L1 capsid protein
- No viral DNA (cannot cause infection)
- Trigger strong antibody response
- Neutralizing antibodies prevent viral entry

**Why vaccine immunity may exceed natural infection:**
- Higher and more consistent antibody levels
- VLPs presented optimally to immune system
- Natural infection may evade immune response

#### Duration of Protection

**HPV vaccine:**
- Clinical trial follow-up: 10+ years of protection documented
- Antibody levels remain well above protective threshold
- No evidence of waning protection
- Boosters not currently recommended

**Hepatitis B vaccine:**
- Immune memory lasts decades
- Even if antibody levels decline, anamnestic response occurs
- Boosters generally not needed for immunocompetent individuals
- Healthcare workers and immunocompromised may need monitoring

### Special Population Considerations

#### Immunocompromised Individuals

**HIV-positive individuals:**
- Should receive HPV vaccine (3-dose series regardless of age)
- May have reduced response
- Hepatitis B vaccine may require higher doses
- Check antibody levels after series

**Solid organ transplant recipients:**
- Vaccinate before transplant when possible
- May need additional doses post-transplant
- Monitor for response

**Cancer patients:**
- Vaccinate before chemotherapy if possible
- May need revaccination after treatment

#### Pregnancy

**HPV vaccine:**
- Not recommended during pregnancy (precaution)
- If inadvertently given, no evidence of harm
- Complete series after pregnancy

**Hepatitis B vaccine:**
- Safe during pregnancy
- Recommended if at risk
- Critical for HBV-positive mothers' infants

### Future Vaccine Development

#### HPV Research Pipeline

**Next-generation vaccines:**
- Broader coverage (more HPV types)
- Therapeutic vaccines for existing infections
- Lower cost vaccines for global access

**Potential developments:**
- Single-dose vaccines (studies ongoing)
- Combination with other vaccines
- Alternative delivery methods (patches, nasal)

#### Hepatitis C Vaccine Challenges

**Why no HCV vaccine exists:**
- High genetic variability
- Limited animal models
- Natural infection doesn't provide lasting immunity
- Research ongoing but challenging

#### Herpes Simplex Vaccine Research

**Status:**
- Multiple candidates in development
- Both prophylactic and therapeutic approaches
- No successful vaccine yet
- Complex immune evasion by virus

### Integration with Sexual Health Services

#### Opportunity Points for Vaccination

**Clinical encounters:**
- STI testing/treatment visits
- Routine health maintenance
- Family planning visits
- Prenatal care
- Adolescent visits

**Strategies to improve uptake:**
- Standing orders for vaccines
- Electronic health record reminders
- Co-administration with other vaccines
- Patient portal reminders

#### Combining Prevention Messages

**Comprehensive approach:**
- Vaccination protects against specific infections
- Condoms protect against many STIs
- PrEP prevents HIV
- Testing identifies infections for treatment
- All strategies work together

---

## Key Takeaways

1. **HPV vaccine prevents cancer** - A safe, effective way to prevent multiple types of cancer
2. **Catch-up vaccination is valuable** - It's not too late if you missed childhood vaccines
3. **Hepatitis B is highly infectious** - Sexual transmission is common; vaccination is protective
4. **Hepatitis A vaccine protects MSM** - Important for those with oral-anal contact risk
5. **Vaccines are safe** - Extensive testing and monitoring confirm safety
6. **Vaccination complements other prevention** - Part of comprehensive sexual health

---

## Recommended Vaccination Schedule

### HPV Vaccine

| Age | Series |
|-----|--------|
| 9-14 years | 2 doses, 6-12 months apart |
| 15-26 years | 3 doses: 0, 2, 6 months |
| 27-45 years | 3 doses (shared decision with provider) |

### Hepatitis B Vaccine

| Population | Series |
|------------|--------|
| Infants | 3 doses starting at birth |
| Adults 19-59 | 3 doses (0, 1, 6 months) or 2-dose Heplisav-B |
| Adults 60+ with risk | Same as above |

### Hepatitis A Vaccine

| Population | Series |
|------------|--------|
| MSM | 2 doses, 6-12 months apart |
| People who use drugs | 2 doses |
| Chronic liver disease | 2 doses |

---

## When to Seek Care

- Want to start or complete a vaccine series
- Need to check vaccination history
- Want to test immunity (Hepatitis B antibodies)
- Exposed to Hepatitis B and not vaccinated
- Have questions about vaccines and your specific health situation

---

## Resources

- **CDC Vaccine Information**: cdc.gov/vaccines
- **Immunization Action Coalition**: immunize.org
- **American Cancer Society**: cancer.org/hpv
- **Hepatitis B Foundation**: hepb.org

---

*This information is for educational purposes. Consult a healthcare provider for personalized medical advice.*

*Last updated: 2024*
